View record

Biomarker Discovery In Seronegative Neuromyelitis Optica (NMO)
33/16/2019-TF/Rare/BMS

ICMR
Jan. 11, 2021

Jan. 10, 2024
Three Year

Seronegative Neuromyelitis Optica
None

None
To determine the frequency of anti AQP-4 and anti MOG antibodies in clinically suspected cases of NMO in India and compare clinical imaging and response to therapy between the two groups and seronegat

Neuromyelitis optica spectrum disorder, Seronegative NMO, biomarker, proteomics, DIA, protein struct
None

72,50,877/-


Dr. Anita Mahadevan/None/Dept. of Neuropathology , NIMHANS, Bangalore

Dr. T.S.Keshava Prasad/None/Center for systmes biology and molecular medicine , Yenopoya research , Mangalore